ANI Pharmaceuticals (ANIP)

[Just the facts maam]

Silvr, if it was after hours, I would be more concerned. In the current guidance, Lalwani left lots of room to raise it. Tailwinds only included 1st quarter opportunities. It should allow for an increase. I also expect an increase in Corti guidance which should also add to the upgraded guidance.

Most likely they announce a launch or two as well and the Q10 filing should speak to litigation regarding Cg Oncology.

Hopefully we also hear about a Rare Disease acquisition.

GLTA